Moreover, βARKct gene therapy in a hindlimb ischemia (HI) model induced GRK2 inhibition and promoted subsequent angiogenesis by suppressing ischemia-induced β2AR downregulation, but the detailed mechanism remains to be explored (44). The gene discussed is ADRB2; the disease is ischemia.